Expert Answered Base di testo: kisspeptina

Back Base di testo: kisspeptina
Cycle planning, bloodwork, side effects, bulking and cutting, TRT and post-cycle therapy.

pamri65

Beginner
Joined
Oct 12, 2026
Messages
27
Reaction score
10
Points
12.00
Potrebbe aver senso, nel caso in cui si decida di fare un ciclo soltanto con un orale tipo l'anavar, usare come base di testo la kisspeptina che a differenza delle hCG non andrebbe a bloccare l'asse e svolgerebbe comunque la stessa azione dell'hcg di mantenere attivi i testicoli...
 
The mechanism of kisspeptin is indeed interesting: it acts higher up the axis, stimulating GnRH, then LH/FSH, and then the testes, whereas HCG only mimics LH and isn’t even a 100% analogue of it. This is an interesting question, and I’ll try to look into it in more detail. I’ll list a few points/problems with using it for this purpose.

1. Kisspeptin acts “higher up” the axis, but the axis will be suppressed by oxandrolone
It stimulates your own GnRH, which then stimulates LH and FSH. But this is exactly why kisspeptin depends more on the condition of the axis itself. The key problem is that oxandrolone itself suppresses the HPTA through negative feedback. If the hypothalamus/pituitary are already strongly suppressed, the response to kisspeptin may be weak or unstable. So the idea itself is physiologically elegant, but while using oxandrolone it becomes less predictable.

2. Will the level be high enough?

Another important point: even if kisspeptin raises endogenous testosterone somewhat, this doesn’t guarantee that the level will be sufficient to compensate for the suppression caused by oxandrolone. So you could potentially still end up with low testosterone, low estradiol, and worse libido, mood, and overall well-being.

So we don’t know whether kisspeptin, while suppression is ongoing, can maintain testosterone at a stable enough level to actually work as a “base” rather than keeping your testosterone below the reference range.

3. Administration protocol

And yes, kisspeptin has another practical problem — its short effect. Kisspeptin is very sensitive to the method and duration of stimulation. Short-term or intermittent administration can maintain LH, while prolonged continuous stimulation in some protocols may lead to a reduced response/desensitization.

For a stable and pronounced effect, the administration protocol seems to be especially important, and there is still no proper standardized protocol.

4. Desensitization

It’s also worth pointing out separately that there is a potential risk of worsening the response of the entire chain. If the kisspeptin system is stimulated too frequently or continuously, the response may weaken over time at several levels. So we’re not simply talking about Leydig cell desensitization as with HCG, but about desensitization of the kisspeptin → GnRH → LH/FSH system, which is considerably more serious.
  • KISS1R receptors on GnRH neurons may become less sensitive;
  • the GnRH neurons themselves may respond less to constant stimulation;
  • further down the chain, the pituitary may produce a weaker LH/FSH response with chronic stimulation.
The worst part is that we don’t know how strong or long-lasting this reduced response might be, or what would then happen during PCT.

So the effect could look like this: at first kisspeptin raises LH/FSH well, but with overly frequent/continuous administration the response becomes weaker. In principle, this is similar to why pulsatile GnRH stimulates the axis, while continuous GnRH can suppress it. Drugs such as leuprorelin, goserelin, and triptorelin are based on this mechanism. They are used, for example, in prostate cancer when strong androgen suppression is needed — this is called medical castration. So what could happen in the end is that we want to stimulate the entire axis but get exactly the opposite effect — even greater suppression.

-----------
My conclusion at this point is that theoretically the idea is interesting, but in practice I wouldn’t consider kisspeptin as a “testosterone base” on an oral cycle to be a reliable replacement for either testosterone or HCG. Kisspeptin is more physiological in terms of its mechanism, but HCG is more predictable in terms of results. At the moment, there is simply still very little scientific data as well as data from enthusiasts.

But if you decide to try it, we would honestly be extremely interested in seeing your blood tests before, during, and after the cycle. That kind of experience would be invaluable for the whole community. And if you’re willing to take the risk and sacrifice yourself for the greater good, I won’t stand in your way :D
 
Yes, you mentioned that earlier, and it can have a negative effect because the body needs estradiol for many processes. During a cycle without testosterone, its level can drop close to zero.

The second point is liver function and worsening of the lipid profile. Oral compounds can significantly worsen both liver function and lipid levels.

And by the way, estradiol is also needed for muscle growth.
 
Yes, you mentioned that earlier, and it can have a negative effect because the body needs estradiol for many processes. During a cycle without testosterone, its level can drop close to zero.

The second point is liver function and worsening of the lipid profile. Oral compounds can significantly worsen both liver function and lipid levels.

And by the way, estradiol is also needed for muscle growth.
What I meant was that, since I’ve only been using oxytocin, adding kisspeptin should be better than just using oxytocin alone—am I right?
 
What I meant was that, since I’ve only been using oxytocin, adding kisspeptin should be better than just using oxytocin alone—am I right?
I guess you mean oxandrolone only (probably a typo), or oxandrolone together with kisspeptin. In general, both options are bad. And depending on how things play out, the second option could hypothetically be even worse than the first.

The point is that we don’t know exactly what to expect from kisspeptin with a protocol like this. I suggested that kisspeptin might suppress the axis even more. The main potential risk of prolonged or improper use of kisspeptin is that the body may gradually become less sensitive to its stimulating effect. At first, kisspeptin can stimulate your own hormonal axis. However, if the stimulation is too strong or too frequent, the response to kisspeptin may weaken over time.

In a worst-case scenario, I tried to compare its action with GnRH agonists: they also initially stimulate LH and FSH, but with continuous stimulation they eventually suppress them. And after prolonged therapy, recovery can be especially slow: in one study, after ≥24 months of use, testosterone returned to normal over a period of two years. Age and duration of therapy obviously had a major influence on recovery, and of course those people did not do PCT, but the data are still quite discouraging.

Similar suppression has also been shown in humans with some long-acting kisspeptin analogues. Whether it would work the same way as GnRH agonists — nobody knows.

I can’t say that improper use of kisspeptin will definitely lead to the same deep and prolonged “chemical castration” as long-acting GnRH agonists. We simply don’t have such data, but we also don’t have data proving that it wouldn’t.

So in the end, I concluded that such an experiment would be extremely useful for the community. But as far as your own risks are concerned, they could be high. Because we know what happens to the hormonal axis if you simply use oxandrolone for 8 weeks, and we roughly know how long recovery takes both with and without PCT. But whether it would work the same way if you used kisspeptin and got the protocol wrong — we don’t know.
 
Back
Top